Market Research Logo

Latvia Pharmaceuticals and Healthcare Report Q2 2015

Latvia Pharmaceuticals and Healthcare Report Q2 2015

BMI View: Market growth forecasts are strong although the country will continue to present a modestopportunity to larger multinational companies on account of its relatively small market size. Meanwhile,tensions between Ukraine and Russia may provide challenges for local manufacturers that had soughtexports to Russia and the Commonwealth of Independent States (CIS) region as a remedy for lacklustredomestic demand in recent years.

Headline Expenditure Projections

Pharmaceuticals: EUR340mn (USD456mn) in 2014 to EUR360mn (USD449mn) in 2015; +5.6% inlocal currency terms and -1.5% in US dollar terms.

Healthcare: EUR0.98bn (USD1.31bn) in 2014 to EUR1.02bn (USD1.27bn) in 2015; +4.1% in localcurrency terms and -2.8% in US dollar terms.


BMI Industry View
SWOT
Political
Economic
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Latvia 2011-2019)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Latvia 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Latvia 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Latvia 2011-2019)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Latvia 2011-2019)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Latvia 2011-2019)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Latvia 2011-2019)
OTC Drug Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Latvia 2011-2019)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Latvia 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Latvia 2013-2019)
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
Economic Analysis
Macro Outlook
Real GDP By Expenditure Breakdown
Risks To Outlook
Table: GDP By Expenditure (Latvia 2011-2018)
Industry Risk Reward Ratings
Central And Eastern Europe Risk/Reward Index
Latvia Risk/Reward Index
Rewards
Risks
Market Overview
Industry Trends And Developments
Epidemiology
Table: Leading Causes of Death, 1990-2010
Table: New Cases of Cancer, 2004-2010
Table: Cumulative Reported Cases of HIV and AIDS, 2000-2010
Healthcare Sector
Healthcare Sector Funding
Healthcare Provision
Table: Hospitals & Beds, 2006-2010
Table: Hospital Beds by Specialty, 2004-2010
Research & Development
Biotechnology
Clinical Trials
Regulatory Development
Regional Collaboration
Intellectual Property Developments
Pricing Regime
Reimbursement Regime
Competitive Landscape
Research-Based Industry
Table: Licences Issued To Companies Engaged In Pharmaceutical Manufacturing And Distribution, 2007-2011
Table: Medicines Consumption According To Marketing Authorisation Holders (turnover in LVL)
Generic Drugmakers
Pharmaceutical Industry Developments
Pharmaceutical Distribution
Table: Wholesale Mark-Up Scheme For Reimbursable Pharmaceuticals, 2008
Table: Wholesalers Market Share, 2010 (%)
Pharmaceutical Retail Sector
Table: Pharmacy Mark-Up Scheme For Reimbursable Pharmaceuticals, 2008
Table: Licences Issued To Pharmacies
Company Profile
Grindeks
Olainfarm
Pfizer
GlaxoSmithKline
Sanofi
Novartis
Merck & Co
Demographic Forecast
Table: Population Headline Indicators (Latvia 1990-2025)
Table: Key Population Ratios (Latvia 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Latvia 1990-2025)
Table: Population By Age Group (Latvia 1990-2025)
Table: Population By Age Group % (Latvia 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report